谷歌浏览器插件
订阅小程序
在清言上使用

Dupilumab improves disease severity in children less than 12 years of age with moderate-severe AD: interim results from PEDISTAD real-world registry

BRITISH JOURNAL OF DERMATOLOGY(2024)

引用 0|浏览9
暂无评分
关键词
atopic dermatitis,dupilumab,pediatrics,real-world practice
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要